Assure Holdings CORP 8-K filings

Assure Holdings Corp. has reached a settlement with Wellgistics Health, Inc. (formerly Danam Health, Inc.), resolving disputes related to a terminated merger agreement and cancelling a $1 million convertible note.

Assure Holdings Corp. has appointed John Price as Chief Financial Officer, effective October 1, 2024, following the resignation of Paul Webster.

Assure Holdings Corp. issued 2,477,082 shares of common stock in exchange for $2.129 million in principal amount of convertible debentures and $348,093 in accrued interest.

Assure Holdings Corp. has amended its debt settlement agreement with Centurion Financial Trust, involving asset assignments, share issuance, and a potential cash payment to resolve a $11 million debenture.

Assure Holdings Corp. has announced the cancellation of its special meeting of stockholders previously scheduled for August 21, 2024.

Assure Holdings Corp. has agreed to sell all of its subsidiaries in exchange for the buyer assuming approximately $2.6 million in debt and other considerations.

Assure Holdings Corp. has reached an agreement with Centurion Financial Trust to settle an $11 million debt through a combination of asset assignments, stock issuance, and a cash payment contingent on a future capital raise.

Assure Holdings Corp. will be delisted from the Nasdaq and move to the OTC Markets after failing to meet minimum bid price and equity requirements, while also issuing shares to settle debts.

Assure Holdings Corp. has announced the postponement of its special stockholder meeting from July 19, 2024, to August 21, 2024.

Assure Holdings Corp. has implemented an 18-for-1 reverse stock split effective July 9, 2024, to comply with NASDAQ's minimum share price requirements.

Assure Holdings Corp. issued 1,592,306 shares of common stock to cancel $436,259.22 in trade accounts payable.

Assure Holdings Corp. has terminated its merger agreement with Danam Health, Inc. due to alleged misrepresentations and breaches of contract by Danam.

Assure Holdings Corp. received a notice from Nasdaq regarding non-compliance due to a late 10-Q filing, adding to existing concerns about its listing status, while the company continues to pursue a merger with Danam Health Inc.

Assure Holdings and Danam Health are merging, with Danam becoming a wholly-owned subsidiary of Assure, shifting focus to pharmaceutical and healthcare services.

Assure Holdings has received an extension to maintain its Nasdaq listing and increased its authorized shares, while also rescheduling a corporate update call related to its merger with Danam Health.

Assure Holdings Corp. has received shareholder approval to increase its authorized shares from 9 million to 250 million, a move intended to facilitate its merger with Danam Health and maintain its Nasdaq listing.

Assure Holdings is reminding its stockholders to vote in favor of a proposal to increase the number of authorized shares, which is critical for the company's future plans.

Assure Holdings Corp. has adjourned its special meeting of stockholders to May 14, 2024, to gather more votes in favor of increasing the number of authorized common shares.

Assure Holdings Corp. announced that its previously released unaudited financial statements for the first three quarters of 2023 should no longer be relied upon due to material accounting errors.

Assure Holdings Corp. received a delisting notice from Nasdaq due to a late annual report filing, adding to existing compliance concerns, while the company continues to pursue a merger with Danam.

Assure Holdings Corp. has entered into a partial waiver and amendment agreement regarding its merger with Danam Health Inc., while also issuing a convertible note and executing share exchange agreements.

Assure Holdings Corp. completed the sale of certain assets to National Neuromonitoring Services, LLC for an initial payment of $2.32 million, with potential for additional earnout payments.

Assure Holdings Corp. exchanged $334,342.75 in convertible note debt for 1,337,371 shares of common stock at a deemed value of $0.25 per share.

Assure Holdings Corp. has entered into an agreement to sell certain assets of its neuromonitoring business to National Neuromonitoring Services for $2.5 million, plus a potential earnout.

Assure Holdings has agreed to sell its intraoperative neuromonitoring (IONM) assets to MPOWER Health for up to $4.5 million, including a potential earnout.

Assure Holdings Corp. cancelled its annual meeting after failing to obtain sufficient votes to approve proposals for increasing authorized common shares and issuing preferred stock.

Assure Holdings has reached a settlement with the Department of Justice, agreeing to pay approximately $1 million to resolve a civil investigation related to past billing practices.

Assure Holdings Corp. and Danam Health, Inc. have agreed to merge in an all-stock transaction, creating a combined company focused on pharmaceutical and healthcare services.

Assure Holdings Corp. is facing potential delisting from the Nasdaq Capital Market after failing to regain compliance with minimum bid price and stockholders' equity requirements.

Assure Holdings Corp. has adjourned its annual meeting to February 9, 2024, to gather more votes for proposals to increase authorized shares and issue preferred stock.